Original article |
Cost valuation in resource-poor settings
1 Swiss Centre for International Health, Swiss Tropical Institute, Basel, Switzerland, 2 Institute of Medical Technology Assessment (iMTA), Erasmus Medical Centre, Rotterdam, The Netherlands and 3 Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
Correspondence: Guy Hutton, Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland. E-mail: guy.hutton{at}unibas.ch
Methods of cost-effectiveness analysis (CEA) have largely been developed for application in Western country settings. Little attention has been paid to the methodological issues in cost valuation in resource-poor settings, where failing exchange rates and severe market distortions require further clarifications of appropriate valuation methods. This paper links insights from social cost-benefit analysis with the current CEA guidelines to develop a more apt approach to cost valuation in resource-poor settings.
Key Words: cost valuation, transferability, economic evaluation, cost-effectiveness analysis, developing countries